BridgeBio has significantly improved the course of an novel solution for ATTR-CM, employing the compound. Preliminary clinical data reveals promising improvements for patients suffering with a severe condition. The https://biotech937778.answerblogs.com/42508027/company-progresses-amyloidosis-management-using-the-drug